Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Natumin Pharma AB

Closing information (x1000 EUR)

Closing information 2022/12 2021/12 2020/12
Turnover 5,907 More Arrow 6,079 Less Arrow 5,901
Financial expenses 46 Less Arrow 37 Less Arrow 24
Earnings before taxes -359 Less Arrow -786 Less Arrow -997
EBITDA -234 Less Arrow -601 Less Arrow -806
Total assets 4,934 More Arrow 5,025 Less Arrow 4,458
Current assets 3,383 Less Arrow 3,276 Less Arrow 2,553
Current liabilities 2,087 Less Arrow 2,022 Less Arrow 751
Equity capital 1,758 More Arrow 2,304 More Arrow 2,677
- share capital 180 More Arrow 196 More Arrow 199
Employees (average) 23 More Arrow 24 More Arrow 25

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 35.6% More Arrow 45.9% More Arrow 60.0%
Turnover per employee 257 Less Arrow 253 Less Arrow 236
Profit as a percentage of turnover -6.1% Less Arrow -12.9% Less Arrow -16.9%
Return on assets (ROA) -6.3% Less Arrow -14.9% Less Arrow -21.8%
Current ratio 162.1% Less Arrow 162.0% More Arrow 339.9%
Return on equity (ROE) -20.4% Less Arrow -34.1% Less Arrow -37.2%
Change turnover 320 Less Arrow 287 More Arrow 481
Change turnover % 6% Less Arrow 5% More Arrow 9%
Chg. No. of employees -1 Equal arrow -1 More Arrow 2
Chg. No. of employees % -4% Equal arrow -4% More Arrow 9%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.